Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 81.45
+3.60 (4.62%)
At close: Apr 16, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 905.4 million as of April 16, 2026.
Market Cap
905.40M
Enterprise Value
982.40M
Revenue
826.43M
Ranking
n/a
PE Ratio
8.29
Stock Price
81.45
Market Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has decreased from 922.07M to 905.40M, a decrease of -1.81%. That is a compound annual growth rate of -2.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 905.40M | -7.29% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bal Pharma | 1.21B |
| Lactose (India) | 1.14B |
| Concord Drugs | 1.09B |
| Pharmaids Pharmaceuticals | 1.09B |
| Makers Laboratories | 947.90M |
| Mercury Laboratories | 907.26M |
| Godavari Drugs | 886.42M |
| Source Natural Foods and Herbal Supplements | 817.17M |